18 Feb 2016
Challenge Aims to Speed Drug Trials ProcessTopics:
The HBS Health Care Initiative is seeking innovative ideas from the science, patient, business, and medical communities on how to transform trials for precision medicine. Through the HBS Precision Trials Challenge, it aims to bring diagnostics and therapies to market faster by reinventing the clinical trials process.
Today, it takes at least 10 years and billions of dollars for one FDA-approved drug to move from research labs to medicine cabinets. Precision medicine will bring faster innovation, targeted medicine, and better treatment.
The Precision Trials Challenge is a community forum to share ideas on how precision diagnostics and therapies can be brought to market faster. Participants will receive feedback from an online community of precision medicine influencers, executives, researchers, doctors, and advocacy groups. A panel of judges will evaluate every application and select three finalists to share a $100,000 prize and receive national media exposure. The winner will be announced in April and will have the opportunity to present at the prestigious 2016 Personalized Medicine Conference to more than 600 influencers. Applications must be submitted by March 13 and finalists will be announced in April.
The challenge is funded by the Kraft Endowment for Advancing Precision Medicine, made possible by a gift from the Kraft Family Foundation, under the leadership of foundation president Robert K. Kraft (MBA 1965).
Class of MBA 1965, Section C